Evidence map›Paper›PMID 33151775›Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2021

Ascorbate attenuates cycling exercise-induced neuromuscular fatigue but fails to improve exertional dyspnea and exercise tolerance in COPD.

Thomas J Hureau, Joshua C Weavil, Simranjit K Sidhu, Taylor S Thurston, Van R Reese, Jia Zhao, Ashley D Nelson, Nathaniel M Birgenheier, Russell S Richardson, Markus Amann

Open access · greenAbstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Fixed-intensity exercise tests to measure exertional dyspnoea in chronic heart and lung populations: a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Nontargeted metabonomics analysis ofFrontiers in microbiology · 2024
    Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Thomas J HureauDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah.ORCID 0000-0002-6993-5723
Joshua C WeavilGeriatric Research, Education, and Clinical Center, Salt Lake City Department of Veterans Affairs Medical Center, Salt Lake City, Utah.ORCID 0000-0002-2032-8498
Simranjit K SidhuDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah.
Taylor S ThurstonDepartment of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah.
Van R ReeseDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah.
Jia ZhaoDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah.
Ashley D NelsonDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah.
Nathaniel M BirgenheierDepartment of Anesthesiology, University of Utah, Salt Lake City, Utah.
Russell S RichardsonDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah.
Markus AmannDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah.
University of Utah · USGeriatric Research Education and Clinical Center · US

Funding

Role of Sensory Neurons in Human Cardiovascular DiseaseR01HL116579 · NHLBI · UNIVERSITY OF UTAH · PI AMANN, MARKUS · 2013 to 2021
$3.4M
Cardiovasomobility Research Training ProgramT32HL139451 · NHLBI · UNIVERSITY OF UTAH · PI SUPIANO, MARK A, WRAY, D. WALTER · 2018 to 2022
$1.4M
Work of Breathing and Oxidative Stress in COPD: Impact on Blood Flow and FatigueR00HL103786 · NHLBI · UNIVERSITY OF UTAH · PI AMANN, MARKUS · 2013 to 2015
$738k
Respiratory muscle work and oxidative stress in COPD: impact on leg blood flow anK99HL103786 · NHLBI · UNIVERSITY OF UTAH · PI AMANN, MARKUS · 2010 to 2011
$161k
NHLBI NIH HHS HL-103786NHLBI NIH HHS HL-116579NHLBI NIH HHS K99 HL103786NHLBI NIH HHS R00 HL103786NHLBI NIH HHS R01 HL116579NHLBI NIH HHS T32 HL 139451NHLBI NIH HHS T32 HL139451RRD VA I01 RX003343VA E1572-PVA E1697-RVA E3207-RVA E6910-R
6 · The paper itself

Abstract

We examined the effect of intravenous ascorbate (VitC) administration on exercise-induced redox balance, inflammation, exertional dyspnea, neuromuscular fatigue, and exercise tolerance in patients with chronic obstructive pulmonary disease (COPD). Eight COPD patients completed constant-load cycling (∼80% of peak power output, 83 ± 10 W) to task failure after intravenous VitC (2 g) or saline (placebo, PL) infusion. All participants repeated the shorter of the two exercise trials (isotime) with the other infusate. Quadriceps fatigue was determined by pre- to postexercise changes in quadriceps twitch torque (ΔQ

Indexed as

Exercise TolerancePulmonary Disease, Chronic ObstructiveAscorbic AcidDyspneaExercise TestHumansMuscle FatigueAscorbic Acidcentral and peripheral fatigueexerciseoxidative stressrespiratory muscle workvitamin C

Identifiers

PMID33151775
PMCPMC7944926
OpenAlexW3096461124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.